Neuromuscular pharmacodynamics of rocuronium in patients with major burns

Anesthesia and Analgesia

Volumn 99, Issue 2, 2004, Pages 386-392

  Han, TaeHyung ^a   Kim, HyeongSeok ^a   Bae, JiYoung ^a   Kim, KwangMin ^a   Martyn, J A Jeevendra ^b  

^a Hallym University   (South Korea)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; FENTANYL; GLYCOPYRRONIUM BROMIDE; MIDAZOLAM; NEOSTIGMINE; NITROUS OXIDE; OXYGEN; PROPOFOL; ROCURONIUM;

ACCELEROMYOGRAPHY; ADULT; ANESTHESIA INDUCTION; ARTICLE; BURN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; HYPERKALEMIA; MAJOR CLINICAL STUDY; MALE; MONITOR; MUSCLE EXCITATION; MYOGRAPHY; NEUROMUSCULAR BLOCKING; PARALYSIS; PHARMACODYNAMICS; PRIORITY JOURNAL;

EID: 3242805913     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000129992.07527.4B     Document Type: Article

References (37)

1. Gronert GA, Theye RA. Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 1975;43:89-99.
2. Martyn J, Goldhill DR, Goudsouzian NG. Clinical pharmacology of muscle relaxants in patients with burns. J Clin Pharmacol 1986;26:680-5.
3. Dwersteg JF, Pavlin EG, Heimbach DM. Patients with burns are resistant to atracurium. Anesthesiology 1986;65:517-20.
4. Marathe PH, Dwersteg JF, Pavlin EG, et al. Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humans. Anesthesiology 1989;70:752-5.
5. Pavlin EG, Haschke RH, Marathe P, et al. Resistance to atracurium in thermally injured rats: the roles of time, activity, and pharmacodynamics. Anesthesiology 1988;69:696-701.
6. Ward JM, Martyn JA. Burn injury induced nicotinic acetylcholine receptor changes on muscle membrane. Muscle Nerve 1993;16:348-54.
7. Kim C, Hirose M, Martyn JAJ. D-Tubocurarine accentuates the burn-induced upregulation of nicotinic acetylcholine receptors at the muscle membrane. Anesthesiology 1995;8:309-15.
8. Martyn JAJ, White DA, Gronert GA, et al. Up and down regulation of skeletal muscle acetylcholine receptors. Anesthesiology 1992;76:822-43.
9. Viby-Mogensen J, Englbaek J, Eriksson LI, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40:59-74.
10. Martyn JA, Matteo RS, Greenblatt DJ, et al. Pharmacokinetics of d-tubocurarine in patients with thermal injury. Anesth Analg 1982;61:241-6.
11. Martyn JA, Greenblatt DJ, Abernethy DR. Increased cimetidine clearance in burn patients. JAMA 1985;253:1288-91.
12. Storella RJ, Martyn JAJ, Bierkamper GG. Anti-curare effect of plasma from patients with thermal injury. Life Sci 1988;43:35-40.
13. Martyn JA. Clinical pharmacology and drug therapy in the burned patients. Anesthesiology 1986;65:67-75.
14. Kim C, Fuke N, Martyn JAJ. Burn injury to rat increases nicotine acetylcholine receptors in the diaphragm. Anesthesiology 1988;68:401-6.
15. Roitberg B. ICU neuropathy and myopathy. Surg Neurol 2003;59:146-7.
16. Ibebunjo C, Martyn JAJ. Disparate dysfunction of skeletal muscles located near and distant from burn site in the rat. Muscle Nerve 200l;24:1283-94.
17. Schuetze SM, Role LW. Developmental regulation of nicotinic acetylcholine receptors. Ann Rev Neurosci 1987;10:403-57.
18. Martyn JA. Basic and clinical pharmacology of the acetylcholine receptor: implications for the use of neuromuscular relaxants. Keio J Med 1995;44:1-8.
19. Badetti C, Pascal L, Bernini V, Manelli JC. Resistance au vecuronium chez le brule: influence de la surface brulee sur la dose efficace 95. Ann Fr Anesth Reanim 1996;15:135-41.
20. Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 1993;79:913-8.
21. Wright PMC, Caldwell JE, Miller RD. Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans. Anesthesiology 1994;81:1110-5.
22. Schultz P, Ibsen M, Østergaard D, Skovgaard LT. Onset and duration of action of rocuronium: from tracheal intubation, through intense block to complete recovery. Acta Anaesthesiol Scand 2001;45:612-7.
23. Kirkegaard-Nielsen H, Caldwell J, Berry PD. Rapid tracheal intubation with rocuronium: a probability approach to determining dose. Anesthesiology 1999;91:131-6.
24. Woolf RL, Crawford MW, Choo SM. Dose response of rocuronium bromide in children anesthetized with propofol: a comparison with succinylcholine. Anesthesiology 1997;87:1368-72.
25. McCourt KC, Salmela L, Mirakhur RK, et al. Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia. Anaesthesia 1998;53:867-71.
26. Andrews JI, Kumar N, Van den Brom RHG, et al. A large sample randomized trial of rocuronium versus succinylcholine in rapid sequence induction of anaesthesia along with propofol. Acta Anaesthesiol Scand 1999;43:4-8.
27. Hagen J, Martyn J, Szyfelbein SK, Goudsouzian NG. Cardiovascular and neuromuscular responses to high-dose pancuronium-metocurine in pediatric burned and reconstructive patients. Anesth Analg 1986;65:1340-4.
28. Martyn JAJ, Goudsouzian NG, Chang YC, et al. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury. Anesthesiology 2000;92:31-7.
29. Martyn JAJ, Chang Y, Goudsouzian NG, Patel SS. Pharmacodynamics of mivacurium chloride in 13- to 18-yr-old adolescents with thermal injury. Br J Anaesth 2002;89:580-5.
30. Viby-Mogensen J, Hanel HK, Hansen E, et al. Serum cholinesterase activity in burned patients. I. Biochemical findings. Acta Anaesthesiol Scand 1975;19:159-68.
31. Collins LM, Bevan JC, Bevan DR, et al. The prolonged duration of rocuronium in Chinese patients. Anesth Analg 2000;91:1526-30.
32. Soriano SG, Sullivan LJ, Venkatakrishnan K, et al. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. Br J Anaesth 2001;86:223-9.
33. van Miert MM, Eastwood NB, Boyd AH, et al. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol 1997;44:139-44.
34. Bertilsson L. Geographical/interracial differences in polymorphic drug oxidation: current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet 1995;29:192-209.
35. Harper NJN, Martlew R, Strang T, Wallace M. Monitoring neuromuscular block by acceleromyography: comparison of the Mini-Acceleromyography with the Myograph 2000. Br J Anaesth 1994;72:411-4.
36. Heier T, Hetland S. A comparison of train-of-four monitoring: mechanomyography at the thumb vs. acceleromyography at the big toe. Acta Anaesthesiol Scand 1999;43:550-5.
37. McCluskey A, Meakin G, Hopkinson JM, Baker RD. A comparison of acceleromyography and mechanomyography for determination of the dose response curve of rocuronium in children. Anaesthesia 1997;52:345-9.